Inventiva (IVA) Return on Equity (2021)
Inventiva (IVA) recorded quarterly Return on Equity of 0.0% in Q1 2021.
Inventiva (IVA) Return on Equity (2021) Analysis & Trends
Inventiva's Return on Equity history runs 1 years deep, the most recent figure standing at 0.0% for Q1 2021.
- In Q1 2021, Return on Equity changed N/A year-over-year to 0.0%; the TTM figure through Mar 2021 stood at 0.0% (changed N/A YoY), while the FY2025 annual figure was 0.03%, changed 0.0% from the prior year.
- Return on Equity was 0.0% for Q1 2021 at Inventiva.
- In the past five years, Return on Equity ranged from a high of 0.0% in Q1 2021 to a low of 0.0% in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | -0.81% |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | -0.04% |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | 0.00% |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | -0.01% |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 0.00% |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | -0.01% |
| 10 | Inventiva | 8.93 Mn | -259.80 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 0.00% |